Abbott Laboratories (ABT): Price and Financial Metrics

ABT POWR Grades

• Stability is the dimension where ABT ranks best; there it ranks ahead of 89.07% of US stocks.
• The strongest trend for ABT is in Quality, which has been heading up over the past 179 days.
• ABT ranks lowest in Momentum; there it ranks in the 26th percentile.

ABT Stock Summary

• ABBOTT LABORATORIES's market capitalization of $179,867,779,804 is ahead of 99.13% of US-listed equities.
• ABBOTT LABORATORIES's stock had its IPO on January 1, 1986, making it an older stock than 93.28% of US equities in our set.
• In terms of volatility of its share price, ABT is more volatile than just 23.35% of stocks we're observing.
• Stocks that are quantitatively similar to ABT, based on their financial statements, market capitalization, and price volatility, are DHR, TMO, UPS, DIS, and VZ.
• ABT's SEC filings can be seen here. And to visit ABBOTT LABORATORIES's official web site, go to www.abbott.com.

ABT Valuation Summary

• ABT's price/sales ratio is 4; this is 81.82% higher than that of the median Healthcare stock.
• Over the past 243 months, ABT's price/earnings ratio has gone down 0.5.

Below are key valuation metrics over time for ABT.

ABT Growth Metrics

Its year over year price growth rate is now at -5.13%.
• Its 5 year price growth rate is now at 140.44%.
• Its 2 year net cashflow from operations growth rate is now at 62.26%.

ABT's revenue has moved up $8,210,000,000 over the prior 15 months.

The table below shows ABT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	45,548	10,243	8,554
2022-03-31	44,514	9,961	7,725
2021-12-31	43,075	10,533	7,071
2021-09-30	42,308	11,264	7,244
2021-06-30	40,233	10,629	6,376
2021-03-31	37,338	9,823	5,724

ABT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ABT has a Quality Grade of B, ranking ahead of 77.76% of graded US stocks.
• ABT's asset turnover comes in at 0.559 -- ranking 70th of 680 Pharmaceutical Products stocks.
• DVAX, RARE, and CORT are the stocks whose asset turnover ratios are most correlated with ABT.

The table below shows ABT's key quality metrics over time.